Cargando…

Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study

INTRODUCTION: Several studies have shown that dipeptidyl peptidase-4 (DPP-4) inhibitors improve insulin secretion during oral glucose tolerance tests. However, the effects of DPP-4 inhibitors on impaired acute insulin responses in the postprandial state in real-world settings are unknown. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohkura, Tsuyoshi, Fujioka, Youhei, Sumi, Keisuke, Nakanishi, Risa, Shiochi, Hideki, Yamamoto, Naoya, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Ohkura, Hiroko, Kato, Masahiko, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065288/
https://www.ncbi.nlm.nih.gov/pubmed/24888256
http://dx.doi.org/10.1007/s13300-014-0071-1
_version_ 1782322055292649472
author Ohkura, Tsuyoshi
Fujioka, Youhei
Sumi, Keisuke
Nakanishi, Risa
Shiochi, Hideki
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Ohkura, Hiroko
Kato, Masahiko
Taniguchi, Shin-ichi
Yamamoto, Kazuhiro
author_facet Ohkura, Tsuyoshi
Fujioka, Youhei
Sumi, Keisuke
Nakanishi, Risa
Shiochi, Hideki
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Ohkura, Hiroko
Kato, Masahiko
Taniguchi, Shin-ichi
Yamamoto, Kazuhiro
author_sort Ohkura, Tsuyoshi
collection PubMed
description INTRODUCTION: Several studies have shown that dipeptidyl peptidase-4 (DPP-4) inhibitors improve insulin secretion during oral glucose tolerance tests. However, the effects of DPP-4 inhibitors on impaired acute insulin responses in the postprandial state in real-world settings are unknown. Therefore, we evaluated the effects of sitagliptin on the acute insulin responses in Japanese patients with type 2 diabetes mellitus (T2DM) using meal tolerance tests. METHODS: Twenty-one patients with T2DM were given a test meal (460 kcal), and plasma glucose and insulin were measured at 0, 30, 60, 120, and 180 min after the meal. The insulinogenic index of all of these patients was below 43.2. The postprandial profiles were assessed at baseline and after 3 months of treatment with 50 mg/day sitagliptin after a meal (n = 11) or were untreated (control group; n = 10). This study was a prospective, open-label, non-blinded, non-randomized, clinical study. RESULTS: Sitagliptin significantly decreased the plasma glucose levels at 60, 120, and 180 min, and significantly increased the plasma insulin levels at 0 and 30 min. There were no significant changes in glucose or insulin in the control group. The insulinogenic index increased significantly in the sitagliptin group compared with the control group (+16.7 vs. +0.1, P < 0.005). However, homeostasis model assessment of insulin resistance and the insulin sensitivity index were not significant different between the two groups. CONCLUSION: Administration of sitagliptin at 50 mg/day after a meal improved the impaired acute insulin response and suppressed postprandial hyperglycemia. Whereas the study is rather small and the design is suboptimal as it is not randomized and not blinded, these results suggest that sitagliptin is effective in Japanese patients with T2DM, many of whom display impaired acute insulin responses after a meal. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13300-014-0071-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4065288
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-40652882014-06-25 Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study Ohkura, Tsuyoshi Fujioka, Youhei Sumi, Keisuke Nakanishi, Risa Shiochi, Hideki Yamamoto, Naoya Matsuzawa, Kazuhiko Izawa, Shoichiro Ohkura, Hiroko Kato, Masahiko Taniguchi, Shin-ichi Yamamoto, Kazuhiro Diabetes Ther Original Research INTRODUCTION: Several studies have shown that dipeptidyl peptidase-4 (DPP-4) inhibitors improve insulin secretion during oral glucose tolerance tests. However, the effects of DPP-4 inhibitors on impaired acute insulin responses in the postprandial state in real-world settings are unknown. Therefore, we evaluated the effects of sitagliptin on the acute insulin responses in Japanese patients with type 2 diabetes mellitus (T2DM) using meal tolerance tests. METHODS: Twenty-one patients with T2DM were given a test meal (460 kcal), and plasma glucose and insulin were measured at 0, 30, 60, 120, and 180 min after the meal. The insulinogenic index of all of these patients was below 43.2. The postprandial profiles were assessed at baseline and after 3 months of treatment with 50 mg/day sitagliptin after a meal (n = 11) or were untreated (control group; n = 10). This study was a prospective, open-label, non-blinded, non-randomized, clinical study. RESULTS: Sitagliptin significantly decreased the plasma glucose levels at 60, 120, and 180 min, and significantly increased the plasma insulin levels at 0 and 30 min. There were no significant changes in glucose or insulin in the control group. The insulinogenic index increased significantly in the sitagliptin group compared with the control group (+16.7 vs. +0.1, P < 0.005). However, homeostasis model assessment of insulin resistance and the insulin sensitivity index were not significant different between the two groups. CONCLUSION: Administration of sitagliptin at 50 mg/day after a meal improved the impaired acute insulin response and suppressed postprandial hyperglycemia. Whereas the study is rather small and the design is suboptimal as it is not randomized and not blinded, these results suggest that sitagliptin is effective in Japanese patients with T2DM, many of whom display impaired acute insulin responses after a meal. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13300-014-0071-1) contains supplementary material, which is available to authorized users. Springer Healthcare 2014-06-03 2014-06 /pmc/articles/PMC4065288/ /pubmed/24888256 http://dx.doi.org/10.1007/s13300-014-0071-1 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Research
Ohkura, Tsuyoshi
Fujioka, Youhei
Sumi, Keisuke
Nakanishi, Risa
Shiochi, Hideki
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Ohkura, Hiroko
Kato, Masahiko
Taniguchi, Shin-ichi
Yamamoto, Kazuhiro
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
title Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
title_full Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
title_fullStr Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
title_full_unstemmed Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
title_short Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
title_sort sitagliptin improves the impaired acute insulin response during a meal tolerance test in japanese patients with type 2 diabetes mellitus: a small-scale real-world study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065288/
https://www.ncbi.nlm.nih.gov/pubmed/24888256
http://dx.doi.org/10.1007/s13300-014-0071-1
work_keys_str_mv AT ohkuratsuyoshi sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT fujiokayouhei sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT sumikeisuke sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT nakanishirisa sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT shiochihideki sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT yamamotonaoya sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT matsuzawakazuhiko sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT izawashoichiro sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT ohkurahiroko sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT katomasahiko sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT taniguchishinichi sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy
AT yamamotokazuhiro sitagliptinimprovestheimpairedacuteinsulinresponseduringamealtolerancetestinjapanesepatientswithtype2diabetesmellitusasmallscalerealworldstudy